Journal - Current Neuropharmacology

Impact Factor

Current: 5.3
5 - Year: 7.9

Ranking & Category

69 th of 261 in Neurosciences
40 th of 261 in Pharmacology & Pharmacy

Topic(s) Covered

3 Topic(s)

View

Covered Disease(s)

1 Disease(s)

View

Aims & Scope

Current Neuropharmacology aims to provide current, comprehensive/mini-reviews. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience. Moreover, position papers and research articles/clinical trials of great novelty and scientific interest might occasionally be considered for publication, along with guest-edited issues in all areas of neuropharmacology and neuroscience.

The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

Abstracted & Indexed in:

BIOSIS Previews BIOSIS Reviews Reports and Meetings British Library Cabell's Directory/Journalytics Cambridge Scientific Abstracts (CSA)/ProQuest Chemical Abstracts Service/SciFinder CNKI Scholar Dimensions EBSCO EMBASE EMBiology ERA 2018 Essential Science Indicators Europe PMC Genamics Journal Seek Google Scholar Index Copernicus Index Medicus J-Gate Journal Citation Reports/Science Edition JournalTOCs MediaFinder®-Standard Periodical Directory MEDLINE/PubMed Norwegian Register OpenAire PMC (PubMed Central) Portico PsycINFO PubsHub QOAM Science Citation Index Expanded™ (SciSearch®) Scilit Scopus Sherpa Romeo Suweco CZ Ulrich's Periodicals Directory

COPE Compliant

Archived in

New eBook

Neurobiology of Mood Disorders
You can view the contents of this
eBook [here].

Endorsement(s)

"By providing succinct reviews of recent advances, Current Neuropharmacology will greatly facilitate readers' comprehension of the big picture."

Solomon H. Snyder
Johns Hopkins Univ., USA